Aviado · Research
Longevity Daily
Thursday, June 25, 2026
Listen
Today's Brief
A landmark meta-analysis of 69 trials and 154,000 adults challenges one of health's most trusted axioms: vitamin D and calcium may not protect against bone fractures after all. New research meanwhile clarifies three actionable fronts for brain aging — poor sleep habits, cardiovascular disease, and menopausal transition all emerge as meaningful Alzheimer's risk factors. Our Aviado krill oil deep-dive offers a rare supplement win: a 12-week blood test that tells you definitively whether it's working for you. Silicon Valley's rapamycin obsession also faces its first real data reality check.
10 stories8 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Three Common Sleep Habits Are Measurably Aging Your Brain Faster
New research identifies specific sleep behaviors — likely including irregular timing, poor quality, and insufficient duration — as measurable drivers of accelerated brain aging. Researchers frame sleep as one of the most powerful modifiable levers available: improving it may slow the pace of brain aging and reduce dementia risk. If you're optimizing your health and not prioritizing sleep hygiene, this study suggests you're leaving one of the biggest interventions on the table.
Read more →Most Cardiovascular Disease Subtypes Are Significantly Linked to Alzheimer's Risk
A comprehensive new analysis finds that most cardiovascular disease subtypes carry significantly elevated associations with Alzheimer's disease, with hypertension, cerebral infarction, and hypotension showing the strongest and most consistent links. The practical message is clear: managing blood pressure and vascular health isn't just heart protection — it's among the most evidence-supported strategies for Alzheimer's prevention. If cardiovascular disease runs in your family, this study adds another compelling reason to keep a close eye on those numbers.
Read more →Menopause Is Now Recognized as a Neurological Transition — With Real Alzheimer's Implications
Growing evidence positions menopause not just as a hormonal event but as a neurological transition that may meaningfully contribute to cognitive decline, heightened Alzheimer's risk, and worse outcomes in women with multiple sclerosis. The estrogen decline that accompanies menopause appears to reduce neuroprotective signaling, creating a window where brain vulnerability increases. For women in perimenopause or beyond, this underscores the case for early, proactive brain-health strategies — both lifestyle and potentially hormonal.
Read more →Supplements & Compounds
69 Trials, 154,000 Adults: Vitamin D and Calcium May Not Protect Against Fractures After All
A major new analysis covering 69 clinical trials and more than 154,000 adults finds that calcium supplements, vitamin D supplements, and their combination do not meaningfully reduce the risk of bone fractures in adults. This directly challenges one of the most widely accepted beliefs in preventive health — and the supplement habits of hundreds of millions of people worldwide. If you're taking vitamin D or calcium specifically for bone protection, this study warrants a serious conversation with your doctor about whether the evidence still supports it. The analysis draws on peer-reviewed trial data from populations around the world.
Read more →Krill Oil Reliably Cuts Triglycerides — But Leaves Cholesterol Untouched: What That Tells You About Your Response
Across multiple high-quality studies, krill oil consistently lowers blood triglycerides while barely affecting LDL or HDL cholesterol — making it one of the rare supplements where your personal response is measurable within 12 weeks using a standard blood test. Take 2–4g daily split across meals; if triglycerides don't drop by at least 10 mg/dL after three months, you're likely a non-responder and should try a different strategy. No guesswork, no indefinite commitment — just clear data.
Read the full Aviado analysis →Research & Papers
Scientists Find a Gene That Speeds Growth and Maturity — But Shortens Lifespan
Researchers publishing in Nature Communications identified a gene in vertebrates that exemplifies antagonistic pleiotropy — it accelerates early growth and sexual maturity while simultaneously shortening lifespan. This is one of the clearest experimental demonstrations of the evolutionary theory that genes favoring early reproduction come at a biological cost to longevity. While the research was conducted in fish, it offers a compelling framework for why aging interventions may need to specifically target early-life programming pathways.
Read more →Accelerated Biological Aging Is Driving the Rise in Early-Onset Cancers — and Each Generation Is Aging Faster
A new study links accelerated biological aging directly to increased incidence of early-onset solid cancers, and finds that each successive generation shows a widening gap between chronological and biological age at diagnosis. The findings suggest that whatever lifestyle or environmental factors are driving premature aging in younger cohorts may also be fueling the well-documented rise in cancers among people under 50. While this is an observational study, it adds urgency to the case for actively tracking and slowing biological age — not just for longevity, but for cancer prevention.
Read more →Lifestyle & Nutrition
Your Body Clock Controls When You Burn the Most Calories — and It Peaks in the Morning
A new study confirms that the human endogenous circadian clock independently drives a 24-hour rhythm in diet-induced thermogenesis — the calories your body burns digesting food — with peak calorie burning in the biological morning and the lowest baseline in the evening. The same meal consumed in the morning will be metabolized more efficiently than the identical meal eaten at night, independent of physical activity. For anyone using meal timing as a health tool, this is strong mechanistic support for front-loading calories earlier in the day.
Read more →Industry & Policy
Bryan Johnson Stopped Rapamycin — and Silicon Valley's Longevity Drug Obsession Is Facing Its First Real Reality Check
Bryan Johnson, the highest-profile self-experimenter in longevity, quietly stopped taking rapamycin in September 2024 after several years of publicized use of the immunosuppressant. TechSpot's analysis examines the growing chasm between longevity drug hype and human evidence, noting that most animal-model results supporting these compounds haven't translated clearly to people. If you've been considering rapamycin, the risk-benefit picture is considerably more complicated than the biohacking community typically acknowledges.
Read more →First-in-Human Trial of 'Telomere Rivers' Immune Rejuvenation Therapy Set to Launch
Biotech company Sentcell is advancing toward an academic Phase 1 trial of a therapy based on "telomere rivers" — structured extracellular telomere fragments that CD4+ T cells reportedly secrete, which produced lifespan-extending effects in mice. Fight Aging! flags important caveats: the original mouse study showed an unusually large lifespan extension in a small cohort, a pattern that historically struggles to replicate. That said, a credible academic funder cleared the path to a first-in-human trial, making this one worth tracking as early data emerges.
Read more →